Point-of-Care Compatibility of Ultra-Sensitive Detection Techniques for the Cardiac Biomarker Troponin I—Challenges and Potential Value
<div><p>Cardiac biomarkers are frequently measured to provide guidance on the well-being of a patient in relation to cardiac health with many assays having been developed and widely utilised in clinical assessment. Effectively treating and managing cardiovascular disease (CVD) relies on...
محفوظ في:
| المؤلف الرئيسي: | Brian Regan (18418860) (author) |
|---|---|
| مؤلفون آخرون: | Richard O’Kennedy (713891) (author), David Collins (2195629) (author) |
| منشور في: |
2018
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Evaluation of Molecularly Imprinted Polymers for Point-of-Care Testing for Cardiovascular Disease
حسب: Brian Regan (18418860)
منشور في: (2019) -
Development of Liposome-Based Immunoassay for the Detection of Cardiac Troponin I
حسب: Radha, Remya
منشور في: (2021) -
Fluorescent Immunoassays for Detection and Quantification of Cardiac Troponin I: A Short Review
حسب: Radha, Remya
منشور في: (2021) -
Founder Mutation in N Terminus of Cardiac Troponin I Causes Malignant Hypertrophic Cardiomyopathy
حسب: Akl C. Fahed (11514346)
منشور في: (2020) -
Can absence of cardiac activity on point-of-care echocardiography predict death in out-of-hospital cardiac arrest? A systematic review and meta-analysis
حسب: Omar Albaroudi (16122240)
منشور في: (2024)